通过D-氨基酸修饰的μ-CnIIICIC抑制人类Nav1.4
Renfei Wu1, Zhuying Wang2, Yuan Quan3
1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China; PeptiOrigin Biotechnology Co., Ltd., Shenzhen 518000, China.
在抑制剂μ-CnIIIC中的D-氨基酸替代显著增强了电压导入通道NaV1.4.4的抑制. 这种修改提高了稳定性和结合亲和力,为神经肌肉疾病治疗提供了一个有前途的策略.
科学领域:
- 生物化学和分子生物学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 电压导入通道NaV1.4是神经肌肉疾病的关键目标.
- 像μ-CnIIIC一样,NaV1.4的现有抑制剂的稳定性很差.
- 研究D-氨基酸修饰以提高类药物稳定性和有效性.
研究的目的:
- 为了研究D-氨基酸替代对μ-CnIIIC对人类电压接道NaV的抑制活性和稳定性的影响1.4.4.
- 阐明改性的增强活性和稳定性背后的分子机制.
主要方法:
- 固体阶段合成以产生D-氨基酸替代的μ-CnIIIC衍生物 (dR-μ-CnIIIC,dK-μ-CnIIIC,dH-μ-CnIIIC).
- 电压导入通道电生理学 (补丁) 来评估抑制活性 (IC50).
- 分子对接和运动模拟来分析结合相互作用.
- 血清稳定性测试用于评估蛋白酶耐药性.
主要成果:
- 与野生型μ-CnIIIC (IC50 = 96.37 nM) 相比,衍生品dR-μ-CnIIIC表现出对NaV1.4 (IC50 = 54.14 nM) 的优异抑制活性.
- 分子建模揭示了dR-μ-CnIIIC通过与NaV1.4子单元强烈的静电和结合相互作用的增强结合亲和力.
- D-氨基酸修饰显著改善了血清稳定性,dR-μ-CnIIIC在480分钟后保持了31.7%的活性.
结论:
- D-氨基酸替代是一种有效的策略,可以增强μ-CnIIIC对NaV的抑制效能和稳定性1.4.4.
- 这些发现为开发稳定且强效的通道向治疗提供了合理的设计方法.
- 这种D-氨基酸替代策略有可能在基于共毒素的药物开发中得到更广泛的应用.
更多相关视频
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
08:30Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents
Published on: January 31, 2020
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
